Manulife (Manufacturers Life Insurance)’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,914
Closed -$30.4K 2966
2025
Q1
$30.4K Sell
23,914
-97,112
-80% -$254K ﹤0.01% 2869
2024
Q4
$393K Sell
121,026
-252
-0.2% -$908 ﹤0.01% 2347
2024
Q3
$399K Sell
121,278
-754
-0.6% -$2.94K ﹤0.01% 2360
2024
Q2
$519K Buy
122,032
+2,483
+2% +$24.2K ﹤0.01% 2204
2024
Q1
$1.76M Buy
119,549
+97,085
+432% +$1.47M ﹤0.01% 1564
2023
Q4
$216K Sell
22,464
-3,284
-13% -$22.7K ﹤0.01% 2588
2023
Q3
$120K Sell
25,748
-54
-0.2% -$269 ﹤0.01% 2746
2023
Q2
$138K Buy
25,802
+1,593
+7% +$9.83K ﹤0.01% 2736
2023
Q1
$174K Hold
24,209
﹤0.01% 2617
2022
Q4
$162K Sell
24,209
-2,579
-10% -$14.1K ﹤0.01% 2650
2022
Q3
$92.7K Sell
26,788
-1,025
-4% -$3.92K ﹤0.01% 2833
2022
Q2
$82K Buy
27,813
+2,576
+10% +$13.5K ﹤0.01% 2964
2022
Q1
$222K Sell
25,237
-6,161
-20% -$68K ﹤0.01% 2702
2021
Q4
$504 Buy
31,398
+270
+0.9% +$5.08K ﹤0.01% 2250
2021
Q3
$652K Sell
31,128
-2,016
-6% -$48.6K ﹤0.01% 2101
2021
Q2
$890K Buy
33,144
+2,335
+8% +$68.4K ﹤0.01% 2066
2021
Q1
$981K Sell
30,809
-1,888
-6% -$45.8K ﹤0.01% 1901
2020
Q4
$747K Buy
32,697
+2,639
+9% +$60.8K ﹤0.01% 1982
2020
Q3
$757K Buy
30,058
+1,454
+5% +$39.7K ﹤0.01% 1787
2020
Q2
$809K Sell
28,604
-2,585
-8% -$44.9K ﹤0.01% 1720
2020
Q1
$182K Buy
31,189
+1,947
+7% +$17.7K ﹤0.01% 2362
2019
Q4
$318K Sell
29,242
-691
-2% -$6.84K ﹤0.01% 2307
2019
Q3
$372K Hold
29,933
﹤0.01% 2183
2019
Q2
$508K Buy
29,933
+3,962
+15% +$68.1K ﹤0.01% 2042
2019
Q1
$467K Buy
25,971
+929
+4% +$16.1K ﹤0.01% 2132
2018
Q4
$318K Sell
25,042
-1,584
-6% -$26.6K ﹤0.01% 2148
2018
Q3
$571K Sell
26,626
-3,269
-11% -$69.7K ﹤0.01% 2182
2018
Q2
$617K Buy
29,895
+4,126
+16% +$92.9K ﹤0.01% 2214
2018
Q1
$648K Sell
25,769
-879
-3% -$21.4K ﹤0.01% 2141
2017
Q4
$506K Buy
26,648
+153
+0.6% +$2.86K ﹤0.01% 2316
2017
Q3
$489K Buy
26,495
+10
+0% +$173 ﹤0.01% 2293
2017
Q2
$463K Buy
26,485
+743
+3% +$14.2K ﹤0.01% 2351
2017
Q1
$479K Buy
25,742
+3,197
+14% +$61.7K ﹤0.01% 2227
2016
Q4
$461K Buy
22,545
+450
+2% +$11.3K ﹤0.01% 2153
2016
Q3
$661K Buy
22,095
+170
+0.8% +$5.06K ﹤0.01% 1898
2016
Q2
$592K Buy
21,925
+1,046
+5% +$23.6K ﹤0.01% 1922
2016
Q1
$360K Buy
20,879
+444
+2% +$8.45K ﹤0.01% 2193
2015
Q4
$632 Buy
20,435
+212
+1% +$6.44K ﹤0.01% 1877
2015
Q3
$433 Buy
20,223
+2,477
+14% +$77.7K ﹤0.01% 2086
2015
Q2
$674 Buy
17,746
+4,213
+31% +$138K ﹤0.01% 1919
2015
Q1
$425 Buy
13,533
+433
+3% +$14.7K ﹤0.01% 2183
2014
Q4
$460 Sell
13,100
-405
-3% -$10.1K ﹤0.01% 2038
2014
Q3
$283 Buy
13,505
+253
+2% +$5.23K ﹤0.01% 2386
2014
Q2
$288K Buy
13,252
+8,351
+170% +$176K ﹤0.01% 2453
2014
Q1
$136 Buy
4,901
+4,050
+476% +$143K ﹤0.01% 2940
2013
Q4
$23 Buy
+851
New +$22.3K ﹤0.01% 3272

Other funds holding MGNX

Manulife (Manufacturers Life Insurance)'s MGNX Position: Q2 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of MacroGenics (MGNX) in Q2 2025, closing a stake of 23,914 shares — an estimated $30.4K sold.

Manulife (Manufacturers Life Insurance) first reported a position in MGNX in Q4 2013 and held it in 46 quarters. The position peaked at $1.76M in Q1 2024. 112 funds tracked by Wall St. Rank hold MGNX as of Q2 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining MacroGenics position as of Q2 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 23,914 MacroGenics shares in Q2 2025, an estimated $30.4K.
  • Manulife (Manufacturers Life Insurance) first reported a position in MacroGenics in Q4 2013 and held it in 46 quarters.
  • Manulife (Manufacturers Life Insurance)'s MacroGenics position peaked at $1.76M in Q1 2024.
  • 112 funds tracked by Wall St. Rank held MacroGenics as of Q2 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.